$HWKN

HAWKINS INC

No enriched coverage for $HWKN in the last 7 days.

$262K
Oldenkamp Jeffrey P.
0%
See all $HWKN insider activity →
Med

Hawkins Expands in Florida With Dave Symonds Acquisition

Hawkins, Inc. (HWKN) acquired Dave Symonds & Associates, Inc. to expand its water treatment business in Florida. The acquisition is expected to boost Hawkins' customer reach and sales. Hawkins' shares have declined 24.9% in the past year. The company has a Zacks Rank #4 (Sell).

Insider Stock Purchases: August 28, 2026

On August 28, 2026, 183 insider stock purchases were reported. Notable transactions include Klarna Group's CEO buying 692,506 shares for $9.95M, Medifast's Kiai Parsa purchasing 41,975 shares for $514,747, and Regenxbio's Ciongoli buying 53,407 shares for $499,675. Hawkins' Lange and FTC Solar's Sadasivam also made significant purchases.

HWKN sentiment & insider activity

Recent HWKN coverage spans financial news, insider activity and corporate actions.

In the last 30 days, HWKN insiders filed 2 SEC Form 4 transactions — 2 purchases ($262K) and no sales. The most active reporter was Oldenkamp Jeffrey P., EXECUTIVE VP AND CFO, with 1 filing.

What's driving HWKN

AlphAI scores every news story that mentions HWKN with an AI model for sentiment and relevance, and aggregates insider trades from HAWKINS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HWKN

Score

Insider Stock Purchases: August 28, 2026

On August 28, 2026, 183 insider stock purchases were reported. Notable transactions include Klarna Group's CEO buying 692,506 shares for $9.95M, Medifast's Kiai Parsa purchasing 41,975 shares for $514,747, and Regenxbio's Ciongoli buying 53,407 shares for $499,675. Hawkins' Lange and FTC Solar's Sadasivam also made significant purchases.

$HWKNLow

HAWKINS INC (HWKN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HAWKINS INC (HWKN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, Yi “Faith” Tang notified us of her resignation from our Board of Directors and its committees, effecti

HAWKINS INC (HWKN): Submission of Matters to a Vote of Security Holders

HAWKINS INC (HWKN) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. At our annual meeting of shareholders held July 29, 2026, the following proposals, each as described in further detail in the definitive proxy statement filed by our company on June 18, 2026 , were voted upon by our

$HWKNMed

HAWKINS INC (HWKN): Results of Operations and Financial Condition

HAWKINS INC (HWKN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hawkins, Inc. Reports First Quarter Fiscal 2027 Results Roseville, Minn., July 29, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027. First Quarter Fiscal Year 2027 Highlights: (All

$HWKNMed

Hawkins (HWKN) Projected to Post Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is expected to release its Q4 2026 earnings on Wednesday, May 13th, with analysts projecting earnings of $0.77 per share and revenue of $255.2840 million. The company currently holds a "Hold" consensus rating from analysts, with an average target price of $200.00. Institutional investors have recently adjusted their stakes in the specialty chemicals company.

$HWKNMed

Hawkins Inc stock (US4202611099): Why its water treatment niche matters more now for steady U.S. gro

Hawkins Inc. specializes in chemical distribution for water treatment and industrial uses, providing a stable investment opportunity due to the non-discretionary nature of water treatment and consistent demand for essential chemicals. The company's strategic focus on the U.S. market, asset-light model, and resilience against economic downturns position it as a reliable pick for investors seeking stability and dividend consistency. Despite potential risks from raw material volatility and regulatory changes, analysts view Hawkins as a steady performer for conservative portfolios.

$HWKNLow

Hawkins Inc (NASDAQ:HWKN) Reports Q3 Revenue and EPS Miss, Stock Reaction Muted

Hawkins Inc (NASDAQ:HWKN) reported a miss on both Q3 fiscal 2026 revenue and non-GAAP EPS, with figures of $244.1 million and $0.72 respectively, falling short of analyst estimates. Despite the miss, the stock's reaction was muted, showing no significant movement in after-hours trading. The company also declared a regular quarterly cash dividend of $0.19 per share, and investors are now looking towards Q4 and full-year 2026 estimates for future performance.

Related tickers